论文部分内容阅读
目的:分析二甲双胍联合苯磺酸左旋氨氯地平共同治疗患者的临床疗效。方法:本文选取2014年3月至2015年5月于本院进行治疗盐敏感性肥胖型轻中度高血压患者共104例的临床资料,依据随机原则分为对照组(单方面选用苯磺酸左旋氨氯地平)与研究组(苯磺酸左旋氨氯地平联合二甲双胍)分别25例,比较两组临床疗效。结果:经研究可知研究组总有效率96.2%高于对照组88.5%,因此,联合两种药物共同治疗的疗效优于对照组(P<0.05)。结论:苯磺酸左旋氨氯地平联合二甲双胍治疗盐敏感性肥胖型轻中度高血压的疗效显著高于单方面选用苯磺酸左旋氨氯地平进行治疗,安全有效,具有临床使用价值。
OBJECTIVE: To analyze the clinical efficacy of metformin combined with levamlodipine besylate in the treatment of patients. Methods: The clinical data of 104 patients with salt-sensitive obese mild to moderate hypertensive treated in our hospital from March 2014 to May 2015 were selected and divided into control group (unilaterally selected with benzenesulfonic acid L-amlodipine) and study group (levamlodipine besylate combined with metformin) were 25 cases, the clinical efficacy of the two groups were compared. Results: The study shows that the total effective rate of 96.2% in the study group was 88.5% higher than that of the control group. Therefore, the combination of the two drugs was superior to the control group (P <0.05). Conclusion: L-amlodipine besylate combined with metformin in the treatment of salt-sensitive obese mild to moderate hypertension was significantly higher than the unilateral use of levamlodipine besylate for treatment, safe and effective, and has clinical value.